Beacon Capital Management LLC (Tennessee)’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01K | Hold |
110
| – | – | ﹤0.01% | 981 |
|
|
2025
Q1 | $944 | Hold |
110
| – | – | ﹤0.01% | 1042 |
|
|
2024
Q4 | $1.18K | Hold |
110
| – | – | ﹤0.01% | 968 |
|
|
2024
Q3 | $625 | Hold |
110
| – | – | ﹤0.01% | 1136 |
|
|
2024
Q2 | $464 | Hold |
110
| – | – | ﹤0.01% | 1000 |
|
|
2024
Q1 | $560 | Sell |
110
-56
| -34% | -$285 | ﹤0.01% | 1001 |
|
|
2023
Q4 | $1.09K | Hold |
166
| – | – | ﹤0.01% | 864 |
|
|
2023
Q3 | $1.35K | Hold |
166
| – | – | ﹤0.01% | 887 |
|
|
2023
Q2 | $1.35K | Hold |
166
| – | – | ﹤0.01% | 887 |
|
|
2023
Q1 | $1.42K | Hold |
166
| – | – | ﹤0.01% | 801 |
|
|
2022
Q4 | $1.54K | Hold |
166
| – | – | ﹤0.01% | 834 |
|
|
2022
Q3 | $2K | Hold |
166
| – | – | ﹤0.01% | 711 |
|
|
2022
Q2 | $2K | Hold |
166
| – | – | ﹤0.01% | 763 |
|
|
2022
Q1 | $2K | Buy |
+166
| New | +$2K | ﹤0.01% | 764 |
|